gastroparesis and glp 1 GLP-1 Gastroparesis: Clinical Safety Considerations – PlexusDx glp-1 gastroparesis class action in

10.1016/j.tcb.2007.07.009 77 SchuppanD.SurabattulaR.WangX

it does not replace it

Concern was initially raised by the findings of the SUSTAIN-6 CVOT that suggested the risk of DR complications was elevated in patients using semaglutide compared with placebo (3.0% vs 1.8%, P = .02)

13 Mitochondrial abnormalities are consistent with acquired MD All patients that underwent a workup for MD demonstrated probable or definite MD by standardized criteria

The missing piece of the puzzle

Doubling time of urine hCG after assisted reproductive technology [PMID: 16213870] Laboratory literature summary: Doubling time of urine hCG after assisted reproductive technology